Winton Group’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
AI
Winton Group's HAE Position: Q2 2026 in Review
Winton Group sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 7,700 shares — an estimated $434K sold.
Winton Group first reported a position in HAE in Q4 2017 and held it in 14 quarters. The position peaked at $6.26M in Q4 2017. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Winton Group reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
- Winton Group sold 7,700 Haemonetics shares in Q2 2026, an estimated $434K.
- Winton Group first reported a position in Haemonetics in Q4 2017 and held it in 14 quarters.
- Winton Group's Haemonetics position peaked at $6.26M in Q4 2017.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.